EVALUATION OF PRIDOPIDINE IN THE TRANSGENIC YAC128 MOUSE MODEL OF HUNTINGTON'S DISEASE

被引：0
|
作者：
Miralles, Marta Garcia [1 ]
Tan, Liang Juin [1 ]
Lim, Madeline [1 ]
Geva, Michal [2 ]
Hayden, Michael R. [1 ,2 ,3 ,4 ]
Pouladi, Mahmoud A. [1 ,3 ,4 ]
机构：
[1] Translat Lab Genet Med, Singapore, Singapore
[2] Teva Pharmaceut, Res & Dev, Netanya, Israel
[3] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC, Canada
[4] Natl Univ Singapore, Dept Med, Yong Loo Lin Sch Med, Singapore, Singapore
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2016年 / 87卷
关键词：
D O I：
10.1136/jnnp-2016-314597.261
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
L6
引用
收藏
页码：A92 / A92
页数：1
相关论文
共 50 条
  • [31] Tetrahydrocarbazoles decrease elevated SOCE in medium spiny neurons from transgenic YAC128 mice, a model of Huntington's disease
    Czeredys, Magdalena
    Maciag, Filip
    Methner, Axel
    Kuznicki, Jacek
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 483 (04) : 1194 - 1205
  • [32] TREATMENT WITH ARIMOCLOMOL DOES NOT LEAD TO RESCUE OF MOTOR OR STRIATAL DEFICITS IN THE YAC128 MOUSE MODEL OF HUNTINGTON'S DISEASE
    Pouladi, M. A.
    Carroll, J.
    Santos, R. Dar
    Bertram, L.
    Hayden, M. R.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 : A14 - A14
  • [33] Light and electron microscopic characterization of the evolution of cellular pathology in YAC128 Huntington's disease transgenic mice
    Bayram-Weston, Zubeyde
    Jones, Lesley
    Dunnett, Stephen B.
    Brooks, Simon P.
    BRAIN RESEARCH BULLETIN, 2012, 88 (2-3) : 137 - 147
  • [34] Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models
    Graham, RK
    Slow, EJ
    Deng, Y
    Bissada, N
    Lu, G
    Pearson, J
    Shehadeh, J
    Leavitt, BR
    Raymond, LA
    Hayden, MR
    NEUROBIOLOGY OF DISEASE, 2006, 21 (02) : 444 - 455
  • [35] Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease
    Huang, Kun
    Kang, Martin H.
    Askew, Caitlin
    Kang, Rujun
    Sanders, Shaun S.
    Wan, Junmei
    Davis, Nicholas G.
    Hayden, Michael R.
    NEUROBIOLOGY OF DISEASE, 2010, 40 (01) : 207 - 215
  • [36] Protection by dietary restriction in the YAC128 mouse model of Huntington's disease: Relation to genes regulating histone acetylation and HTT
    Moreno, Cesar L.
    Ehrlich, Michelle E.
    Mobbs, Charles V.
    NEUROBIOLOGY OF DISEASE, 2016, 85 : 25 - 34
  • [37] Ethyl-EPA treatment improves motor dysfunction, but not neurodegeneration in the YAC128 mouse model of Huntington disease
    Van Raamsdonk, JM
    Pearson, J
    Rogers, DA
    Lu, G
    Barakauskas, VE
    Barr, AM
    Honer, WG
    Hayden, MR
    Leavitt, BR
    EXPERIMENTAL NEUROLOGY, 2005, 196 (02) : 266 - 272
  • [38] Age-dependent alterations in the cortical entrainment of subthalamic nucleus neurons in the YAC128 mouse model of Huntington's disease
    Callahan, Joshua W.
    Abercrombie, Elizabeth D.
    NEUROBIOLOGY OF DISEASE, 2015, 78 : 88 - 99
  • [39] Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease
    Franciosi, Sonia
    Ryu, Jae K.
    Shim, Yaein
    Hill, Austin
    Connolly, Colum
    Hayden, Michael R.
    McLarnon, James G.
    Leavitt, Blair R.
    NEUROBIOLOGY OF DISEASE, 2012, 45 (01) : 438 - 449
  • [40] Laquinimod Treatment Improves Myelination Deficits at the Transcriptional and Ultrastructural Levels in the YAC128 Mouse Model of Huntington Disease
    Marta Garcia-Miralles
    Nur Amirah Binte Mohammad Yusof
    Jing Ying Tan
    Carola I. Radulescu
    Harwin Sidik
    Liang Juin Tan
    Haim Belinson
    Neta Zach
    Michael R. Hayden
    Mahmoud A. Pouladi
    Molecular Neurobiology, 2019, 56 : 4464 - 4478
12345